Westborough, MA, United States of America

Salam A Shaaban

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 3.2

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • Westborough, MA (US) (2011)
  • Boston, MA (US) (2014)

Company Filing History:


Years Active: 2011-2014

Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: Innovations by Salam A. Shaaban

Introduction

Salam A. Shaaban is an accomplished inventor based in Westborough, MA (US). He has made significant contributions to the field of cancer research through his innovative patents. With a total of three patents to his name, his work focuses on identifying agents that inhibit mesenchymal-like tumor cells and their formation.

Latest Patents

One of his latest patents is titled "Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation." This invention provides tumor cell preparations for use as models of the epithelial-mesenchymal transition (EMT) process. It aims to identify anti-cancer agents that can inhibit EMT, stimulate mesenchymal-epithelial transition (MET), or inhibit the growth of mesenchymal-like cells. Such agents are particularly useful when combined with other anti-cancer drugs like EGFR and IGF-1R kinase inhibitors.

Another significant patent is "Inhibition of EMT induction in tumor cells by anti-cancer agents." This invention outlines methods for identifying agents that prevent tumor cells from undergoing EMT, thereby impairing their mobility and inhibiting tumorigenicity. The patent also includes compositions comprising these agents and methods for their preparation and use. Notably, it suggests using inhibitors of PAK2 kinase, which may also inhibit PAK1 kinase, in combination with other anti-cancer agents.

Career Highlights

Salam A. Shaaban is currently associated with Osi Pharmaceuticals, Inc., where he continues to advance his research in cancer therapeutics. His work has been instrumental in developing innovative solutions to combat cancer, particularly through the inhibition of tumor cell transitions.

Collaborations

He has collaborated with notable colleagues, including Julie Kan and John D. Haley, to further enhance the impact of his research and innovations in the field.

Conclusion

Salam A. Shaaban's contributions to cancer research through his patents demonstrate his commitment to finding effective treatments for tumor cells. His innovative approaches have the potential to significantly impact cancer therapy and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…